<DOC>
	<DOCNO>NCT00310232</DOCNO>
	<brief_summary>The general objective study improve Quality Life ( QoL ) select patient advanced carcinoma lung . The specific objective evaluate effect treatment epoetin alfa ( recombinant human erythropoietin ) anemia relate QoL anemia non-small cell lung cancer patient advance stage disease underlie anemia malignancy .</brief_summary>
	<brief_title>Epoetin Alfa Advanced Non-Small Cell Lung Cancer ( EPO-CAN-20 )</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>1 . Histologically confirm nonsmall cell lung cancer ( squamous cell , large cell , adenocarcinoma , combination ) , clinical pathological stage III IV , recurrent disease ; 2 . Hemoglobin level 120 g/L ; 3 . At least 18 year age ; 1 . Systemic platinumbased chemotherapy lung cancer previous two month plan platinumbased chemotherapy within next three month ; 2 . Patients previously treat high dose thoracic radiation ( &gt; 10 fraction ) , surgery , without objective evidence disease recurrence ; 3 . Planned high dose thoracic radiation therapy ( &gt; 10 fraction ) ; 4 . A clinically active malignancy , underlie lung cancer expect influence QoL ; 5 . Expected survival three month le ; 6 . ECOG Performance status 3 4 ( see Appendix D ) ; 7 . Multiple CNS metastasis single CNS lesion demonstrate radiographic stability ( Screening CT head require symptomatic , radiographic followup single resect lesion require ) ; 8 . Blood transfusion within last 14 day ; 9 . Previous use erythropoietin ; 10 . Anemia due factor cancer / radiotherapy ( e.g . hemolysis gastrointestinal bleeding ) ; 11 . Evidence untreated folate vitamin B12 deficiency ; 12 . History uncontrolled hypertension diastolic blood pressure great 100 mm Hg ; 13 . History seizure disorder ; 14 . Known hypersensitivity mammalian cellderived product , albumin component study drug ; 15 . Pregnancy , lactation parturition within previous 30 day ; 16 . Unwillingness inability complete require QoL questionnaire ; 17 . Mental incompetence , include psychiatric addictive disorder would preclude meaningful completion questionnaire ; 18 . Geographically inaccessible treatment followup evaluation ; 19 . Currently enrol ongoing therapeutic study ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2006</verification_date>
	<keyword>Quality Life</keyword>
	<keyword>Blood transfusion</keyword>
</DOC>